Abstract
Parkinson’s disease (PD) is a common neurodegenerative disease that impairs motor functions in the affected individuals, causing increased dependence and even mortality eventually. Therefore, it has become a significant resources and financial burden to the society. Scientists and companies have carried out a myriad of studies to study potentially effective drugs to slow or cure the disease, but they barely pass the Phase III stage of clinical trials. Under these circumstances, establishing the pathogenic mechanisms is really the key to removal of obstacles in the way of mitigating PD. Degeneration of dopaminergic neurons is known as a cause of motor manifestation in PD. Instead of approaching PD from the traditional α-synuclein theory, this review emphasizes on dopaminergic neurons per se to discuss their unique features and how they may implicate in PD development and progression. Some latest findings and potential future directions are also summarized and discussed in this review.
Publisher
Darcy & Roy Press Co. Ltd.
Reference22 articles.
1. Beitz J. M. (2014). Parkinson's disease: a review. Frontiers in bioscience (Scholar edition), 6(1), 65–74.
2. WHO.int. 2022. Parkinson disease. [online] Available at: [Accessed 10 September 2022].
3. Dorsey, E. R., Sherer, T., Okun, M. S., & Bloem, B. R. (2018). The Emerging Evidence of the Parkinson Pandemic. Journal of Parkinson's disease, 8(s1), S3–S8.
4. Yang, W. et al. (2020). Current and projected future economic burden of Parkinson's disease in the U.S. NPJ Parkinson's disease, 6, 15.
5. UCL Queen Square Institute of Neurology. 2022. Medical costs of Parkinson’s £3,000/year higher than others of same age. [online] Available at: [Accessed 10 September 2022].
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献